Evidence map›Paper›PMID 32780778›Full record

ArticlePLoS pathogens2020

MrpH, a new class of metal-binding adhesin, requires zinc to mediate biofilm formation.

Wangshu Jiang, Wimal Ubhayasekera, Michael C Breed, Allison N Norsworthy, Nina Serr, Harry L T Mobley, Melanie M Pearson, Stefan D Knight

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Article
  3. Development of a suite ofApplied and environmental microbiology · 2024
    Article
  4. Article
  5. Unveiling the hidden arsenal: new insights intoFrontiers in cellular and infection microbiology · 2024
    Review
  6. More than just pattern recognition: Prediction of uncommon protein structure features by AI methods.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Iron Deprivation Modulates the Exoproteome inFrontiers in cellular and infection microbiology · 2022
    Article
  16. Article
  17. Into the understanding the multicellular lifestyle ofFrontiers in cellular and infection microbiology · 2022
    Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Wangshu JiangDepartment of Cell and Molecular Biology, Uppsala University, Biomedical Center, Uppsala, Sweden.ORCID 0000-0003-1570-1208
Wimal UbhayasekeraDepartment of Cell and Molecular Biology, Uppsala University, Biomedical Center, Uppsala, Sweden.ORCID 0000-0001-5223-2434
Michael C BreedDepartment of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI, United States of America.
Allison N NorsworthyDepartment of Microbiology, New York University School of Medicine, New York, NY, United States of America.
Nina SerrDepartment of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI, United States of America.ORCID 0000-0003-1335-0790
Harry L T MobleyDepartment of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI, United States of America.ORCID 0000-0001-9195-7665
Melanie M PearsonDepartment of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI, United States of America.ORCID 0000-0003-4553-3276
Stefan D KnightDepartment of Cell and Molecular Biology, Uppsala University, Biomedical Center, Uppsala, Sweden.ORCID 0000-0002-7180-8758
University of Michigan · USUppsala University · SENew York University · US

Funding

Reciprocal Control of Motility and Adherence in UTIR01AI059722 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PEARSON, MELANIE M. · 2005 to 2024
$7.4M
Contribution of Novel Frimbriae to Proteus Mirabilis VirulenceK22AI083743 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI PEARSON, MELANIE M. · 2011 to 2013
$359k
NIAID NIH HHS K22 AI083743NIAID NIH HHS R01 AI059722
6 · The paper itself

Abstract

Proteus mirabilis, a Gram-negative uropathogen, is a major causative agent in catheter-associated urinary tract infections (CAUTI). Mannose-resistant Proteus-like fimbriae (MR/P) are crucially important for P. mirabilis infectivity and are required for biofilm formation and auto-aggregation, as well as for bladder and kidney colonization. Here, the X-ray crystal structure of the MR/P tip adhesin, MrpH, is reported. The structure has a fold not previously described and contains a transition metal center with Zn2+ coordinated by three conserved histidine residues and a ligand. Using biofilm assays, chelation, metal complementation, and site-directed mutagenesis of the three histidines, we show that an intact metal binding site occupied by zinc is essential for MR/P fimbria-mediated biofilm formation, and furthermore, that P. mirabilis biofilm formation is reversible in a zinc-dependent manner. Zinc is also required for MR/P-dependent agglutination of erythrocytes, and mutation of the metal binding site renders P. mirabilis unfit in a mouse model of UTI. The studies presented here provide important clues as to the mechanism of MR/P-mediated biofilm formation and serve as a starting point for identifying the physiological MR/P fimbrial receptor.

Indexed as

BiofilmsAdhesins, BacterialAmino Acid SequenceFimbriae ProteinsHumansProteus InfectionsProteus mirabilisSequence AlignmentUrinary Tract InfectionsZincAdhesins, BacterialFimbriae ProteinsMrpH protein, Proteus mirabilisZinc

Identifiers

PMID32780778
PMCPMC7444556
OpenAlexW3048491903

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.